Principal Investigator
更新時間：2025-12-16
- Principal Investigator
- Clinical Trial Experience (year) 23 years 9 個月
Highlights
2. stent for branched PA stenosis
3. Amplazter ASD device
4. Venus P-Valve
5. Prospective, multi-center, double-blind, randomized, placebo-controlled, parallel-group study assessing the efficacy and safety of macitentan in Fontan-palliated adult and adolescent subjects.
6. Prospective, multi-center, single-arm, open-label, long-term study assessing the safety, tolerability, and effectiveness of macitentan in Fontan-palliated adult and adolescent subjects
7. Multicenter, open-label, study to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of LCZ696 followed by a 52-week randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared to enalapril in pediatric patients from 1 month to < 18 years of age with heart failure due to systemic left ventricle systolic dysfunction.
8. A multicenter study to evaluate long-term safety and tolerability of open label sacubitril/valsartan in pediatric patients with heart failure due to systemic left ventricle systolic dysfunction who have completed study CLCZ696B2319
Study Area
- Pediatric cardiology
Professional Experiences
Visiting Staff
Pediatric Cardiology
1986- 迄今
Education
National Taiwan University College of Medicine
Doctor
1973- 迄今
Clinical Trials List
2016
Total 17
-
I 0
-
I/II 0
-
II 2
-
II/III 3
-
III 12
-
IV 0
-
Others 0
Number of Studies by Scale
0件
Taiwan Multiple Center
Taiwan Single Center
0Cases
Taiwan Multiple Center
0Cases
Multi-Regional Multi-Center
17Cases
